Drug Shortage Report for GD-VENLAFAXINE XR

Last updated on 2018-01-25 History
Report ID 27249
Drug Identification Number 02360039
Brand name GD-VENLAFAXINE XR
Common or Proper name VENLAFAXINE
Company Name GENMED A DIVISION OF PFIZER CANADA ULC
Active Ingredient(s) VENLAFAXINE
Strength(s) 75MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL
Packaging size 90s
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-12-18
Estimated end date
Actual end date 2018-01-24
Shortage status Resolved
Updated date 2018-01-25
Company comments Other presentations available: GD-Venlafaxine 37.5mg
Health Canada comments
Contact Address 17300 TRANS CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-800-387-4974 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2018-01-25 English Compare
v18 2018-01-24 French Compare
v17 2018-01-24 English Compare
v16 2018-01-11 French Compare
v15 2018-01-11 English Compare
v14 2018-01-05 French Compare
v13 2018-01-05 English Compare
v12 2017-12-20 French Compare
v11 2017-12-20 English Compare
v10 2017-12-20 English Compare
v9 2017-12-19 English Compare
v8 2017-12-18 French Compare
v7 2017-12-18 English Compare
v6 2017-12-18 English Compare
v5 2017-12-14 French Compare
v4 2017-12-14 English Compare
v3 2017-11-07 English Compare
v2 2017-10-27 French Compare
v1 2017-10-27 English Compare